Total raised
—
Last: Pre-Seed 2025-09
Stage
Pre-Seed
Founded
2025
Headcount
2
HQ
Israel
Sector
Health Tech & Life Sciences
About
Proventis is developing a long-term, reversible implant for male contraception. The implant is intended to provide reliable contraceptive protection without requiring daily attention or interrupting routine activities. It can be placed by a physician in a brief, minimally invasive in-office procedure and later deactivated to restore fertility. The company focuses on advancing reproductive health through scientific research and collaborations with urologists, medical experts, and investors in the field of male contraceptives.
Funding history · 1 round · — total
2025-09
Pre-Seed
Undisclosed
Company Intelligence Q&A
Structured intelligence from startupim data — optimized for AI retrieval and grounding.
- What is Proventis Med's primary focus?
- Proventis Med is developing a long-term, reversible implant for male contraception.
- When was Proventis Med founded?
- Proventis Med was founded in January 2025.
- What is the current employee count for Proventis Med?
- Proventis Med has 2 employees.
- What is Proventis Med's current funding stage?
- Proventis Med is currently in the Pre-Seed funding stage.
- When did Proventis Med secure its last funding round?
- Proventis Med secured its last funding round, a Pre-Seed round, in September 2025.
- Which investor participated in Proventis Med's Pre-Seed round?
- NGT HealthCare II participated in Proventis Med's Pre-Seed funding round in September 2025.
- Who are the founders of Proventis Med?
- The founders of Proventis Med are Bar Evyatar, Netta Nir-Hirshberg, and Netta Hirshberg.
- What sector does Proventis Med operate in?
- Proventis Med operates in the Health Tech & Life Sciences sector.
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life Sciences